Home › NDC Lookup › RxCUI directory › RxCUI 2739998

5 ML nusinersen 10 MG/ML Injection [Spinraza] — RxCUI 2739998

RxNorm drug concept · Semantic branded drug
RxCUI 2739998 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2739998
Official name5 ML nusinersen 10 MG/ML Injection [Spinraza]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSpinraza 50 MG per 5 ML Injection; SPINRAZA 50 MG in 5 ML Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)375 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nusinersen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Spinraza treats spinal muscular atrophy (SMA) in children and adults. SMA is a genetic condition caused by too little SMN protein. Spinraza helps your body make more of it.
  • It is injected into the fluid around your spinal cord by a trained healthcare professional. You start with a few loading doses, then get maintenance doses about every 4 months. You...
  • Spinraza can lower platelets, affect clotting and put stress on the kidneys. Your team checks platelets, clotting and urine protein before each dose. This helps catch problems earl...
  • Common ones include fever, headache, vomiting, back pain, respiratory infections and constipation, depending on age and type of SMA. Call your care team about unusual bleeding or b...
📖 Read our full Nusinersen Injection guide →

🕸️ Concept Web — How 5 ML nusinersen 10 MG/ML Injection [Spinraza] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML nusinersen 10 MG/ML Injection [Spinraza] RxCUI 2739998

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nusinersen 1863556
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Spinraza 1863561
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nusinersen Injection 1863559
    • Nusinersen Injectable Product 1863558
    • Nusinersen Injection [Spinraza] 1863563
    • Spinraza Injectable Product 1863564
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 5 ML nusinersen 10 MG/ML Injection SCD · 2739995
  • Nusinersen 10 MG/ML SCDC · 2739994
  • Nusinersen Injection SCDF · 1863559
  • Nusinersen Injectable Product SCDG · 1863558

Brand-Name Concepts

  • Nusinersen 10 MG/ML [Spinraza] SBDC · 2739997
  • Nusinersen Injection [Spinraza] SBDF · 1863563
  • Spinraza Injectable Product SBDG · 1863564
  • Spinraza BN · 1863561

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2739998 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64406-0036-01 1 VIAL, SINGLE-USE in 1 BOX (64406-036-01) / 5 mL in 1 VIAL... Spinraza Biogen Inc. 2026-03-27
64406-0037-01 1 VIAL, SINGLE-USE in 1 BOX (64406-037-01) / 5 mL in 1 VIAL... Spinraza Biogen Inc. 2026-03-27
64406-0058-01 1 VIAL, SINGLE-USE in 1 BOX (64406-058-01) / 5 mL in 1 VIAL... Spinraza Biogen Inc. 2016-12-23
Observed labelers: Biogen Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.